Form 4: Kiniksa Pharmaceuticals CEO Sanj K. Patel Reports Share Disposals
SEC Form 4 Filing
Sanj K. Patel, Chairman & CEO of Kiniksa Pharmaceuticals International, plc, reported the disposal of Class A Ordinary Shares to cover tax obligations related to vested Restricted Share Units (RSUs).
Summary
- On March 16, 2025, Sanj K. Patel, Chairman & CEO of Kiniksa Pharmaceuticals International, plc, disposed of 6,569 Class A Ordinary Shares to satisfy tax withholding obligations related to the vesting of Restricted Share Units (RSUs).
- Additionally, 2,004 Class A Ordinary Shares were disposed of at a price of $22.61.
- Following these transactions, Patel directly owns 84,116 Class A Ordinary Shares.
- Patel also indirectly owns 109,795 Class A Common Shares held by The Marina 2016 Irrevocable Trust.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing share disposals, primarily for tax obligations. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when company insiders, like the CEO, trade in their company's stock. It provides transparency to the market regarding the transactions of company leadership.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their insiders.
- The information disclosed is consistent with SEC regulations and reporting requirements.
- Similar filings can be observed for executives at comparable pharmaceutical companies like Amgen, Regeneron, and Vertex Pharmaceuticals.
Stakeholder Impact
- The disposal of shares by the CEO could have a minor impact on shareholder sentiment, but is likely viewed as a routine transaction for tax purposes.
Key Dates
| Date | Description |
|---|---|
| June 23, 2016 | Date of The Marina 2016 Irrevocable Trust agreement. |
| March 16, 2021 | Grant date of the Restricted Share Units (RSUs) that vest over a four-year period. |
| March 16, 2025 | Date of the reported transactions: disposal of shares for tax obligations and other disposals. |
| March 19, 2025 | Date of signature for the Form 4 filing. |
Keywords
Kiniksa Pharmaceuticals, Sanj K. Patel, Class A Ordinary Shares, Restricted Share Units, RSU, Form 4, Beneficial Ownership, Share Disposal, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.